The U.S. government's negotiated prices for prescription drugs are still significantly higher than those in other wealthy nations, highlighting the country's unique pricing challenges.
The 30-day supply of nine drugs will cost Medicare $17,581 in 2026, significantly higher compared to $6,725 in Sweden, showcasing the disparity in drug pricing.
Experts, like Stacie Dusetzina from Vanderbilt University, indicate that the U.S. recognizes its overpayment for medications compared to other countries.
The new prices for 10 high-cost medicines under Medicare are expected to save $6 billion in 2026, indicating a move towards more affordable healthcare.
#prescription-drugs #healthcare-pricing #medicare #inflation-reduction-act #international-pricing-comparison
[
Collection
]
[
|
...
]